Skandinaviska Enskilda Banken (SEB)’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.36M | Hold |
59,626
| – | – | 0.01% | 558 |
|
2025
Q1 | $1.8M | Hold |
59,626
| – | – | 0.01% | 589 |
|
2024
Q4 | $2.08M | Hold |
59,626
| – | – | 0.01% | 568 |
|
2024
Q3 | $2.39M | Hold |
59,626
| – | – | 0.01% | 553 |
|
2024
Q2 | $2.85M | Hold |
59,626
| – | – | 0.01% | 486 |
|
2024
Q1 | $2.58M | Hold |
59,626
| – | – | 0.01% | 521 |
|
2023
Q4 | $3.02M | Hold |
59,626
| – | – | 0.02% | 489 |
|
2023
Q3 | $2.71M | Hold |
59,626
| – | – | 0.02% | 472 |
|
2023
Q2 | $2.45M | Buy |
59,626
+40,770
| +216% | +$1.67M | 0.02% | 511 |
|
2023
Q1 | $674K | Sell |
18,856
-880
| -4% | -$31.5K | ﹤0.01% | 740 |
|
2022
Q4 | $745K | Sell |
19,736
-1,142
| -5% | -$43.1K | 0.01% | 699 |
|
2022
Q3 | $923K | Hold |
20,878
| – | – | 0.01% | 696 |
|
2022
Q2 | $773K | Hold |
20,878
| – | – | 0.01% | 745 |
|
2022
Q1 | $773K | Hold |
20,878
| – | – | ﹤0.01% | 791 |
|
2021
Q4 | $638K | Hold |
20,878
| – | – | ﹤0.01% | 824 |
|
2021
Q3 | $700K | Sell |
20,878
-11,415
| -35% | -$383K | ﹤0.01% | 837 |
|
2021
Q2 | $1.29M | Sell |
32,293
-22,200
| -41% | -$885K | 0.01% | 766 |
|
2021
Q1 | $2.45M | Buy |
54,493
+10,889
| +25% | +$490K | 0.02% | 598 |
|
2020
Q4 | $2.47M | Sell |
43,604
-55
| -0.1% | -$3.11K | 0.02% | 570 |
|
2020
Q3 | $2.07M | Sell |
43,659
-50,941
| -54% | -$2.42M | 0.02% | 560 |
|
2020
Q2 | $5.58M | Buy |
94,600
+7,200
| +8% | +$425K | 0.05% | 307 |
|
2020
Q1 | $4.13M | Sell |
87,400
-8,600
| -9% | -$407K | 0.04% | 304 |
|
2019
Q4 | $5.8M | Buy |
96,000
+1,400
| +1% | +$84.6K | 0.05% | 298 |
|
2019
Q3 | $5.67M | Buy |
94,600
+86,500
| +1,068% | +$5.18M | 0.05% | 300 |
|
2019
Q2 | $521K | Buy |
+8,100
| New | +$521K | ﹤0.01% | 730 |
|
2016
Q2 | – | Sell |
-6,400
| Closed | -$259K | – | 724 |
|
2016
Q1 | $259K | Sell |
6,400
-8,300
| -56% | -$336K | ﹤0.01% | 677 |
|
2015
Q4 | $901K | Buy |
+14,700
| New | +$901K | 0.01% | 528 |
|